We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$11.1B
AUM Growth
+$6.54B
Cap. Flow
+$7.22B
Cap. Flow %
65.14%
Top 10 Hldgs %
32.66%
Holding
1,539
New
487
Increased
956
Reduced
24
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 15.62%
2 Consumer Discretionary 8.67%
3 Financials 6.74%
4 Consumer Staples 6.64%
5 Healthcare 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABUS icon
1451
Arbutus Biopharma
ABUS
$915M
$38.1K ﹤0.01%
20,000
+10,000
+100% +$23.5K
NVRI icon
1452
Enviri
NVRI
$620M
$38K ﹤0.01%
+10,082
New +$55.9K
IPG
1453
PUT
DELISTED
Interpublic Group of Companies
IPG
$36.4K ﹤0.01%
8,000
+4,000
+100% +$113K
EAR
1454
DELISTED
Eargo, Inc. Common Stock
EAR
$34.5K ﹤0.01%
+1,667
New +$45K
GMDA
1455
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$34.3K ﹤0.01%
21,786
+10,893
+100% +$24.8K
UP icon
1456
Wheels Up
UP
$198M
$32.3K ﹤0.01%
+142
New +$56.9K
RIVN icon
1457
PUT
Rivian
RIVN
$23.2B
$32K ﹤0.01%
+12,000
New +$409K
MDWD icon
1458
MediWound
MDWD
$185M
$27.9K ﹤0.01%
2,857
+1,428
+100% +$18K
QMCO icon
1459
Quantum Corp
QMCO
$474M
$22.1K ﹤0.01%
+1,025
New +$32.9K
NE icon
1460
CALL
Noble Corp
NE
$6.51B
$21.7K ﹤0.01%
+20,000
New +$591K
CDAK
1461
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$18.4K ﹤0.01%
24,000
+14,000
+140% +$29.4K
BTU icon
1462
CALL
Peabody Energy
BTU
$2.9B
$18.2K ﹤0.01%
+8,000
New +$180K
RY icon
1463
PUT
Royal Bank of Canada
RY
$293B
$12.1K ﹤0.01%
+2,400
New +$230K
TMQ
1464
Trilogy Metals
TMQ
$656M
$12K ﹤0.01%
+20,000
New +$13.1K
LTCH
1465
DELISTED
Latch, Inc. Common Stock
LTCH
$10.3K ﹤0.01%
+11,074
New +$12.7K
NAVB
1466
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$5.54K ﹤0.01%
20,100
+10,050
+100% +$4.69K
IJR icon
1467
PUT
iShares Core S&P Small-Cap ETF
IJR
$112B
$2.36K ﹤0.01%
+200
New +$19.4K
HURA
1468
TuHURA Biosciences
HURA
$136M
$2.08K ﹤0.01%
11
+5
+83% +$1.6K
LTCH
1469
CALL
DELISTED
Latch, Inc. Common Stock
LTCH
$2K ﹤0.01%
+20,000
New +$22.9K
TELL
1470
CALL
DELISTED
Tellurian Inc.
TELL
$1.6K ﹤0.01%
24,000
+12,000
+100% +$43.3K
ALGM icon
1471
Allegro MicroSystems
ALGM
$8.16B
-15,617
Closed -$324K
AVNT icon
1472
Avient
AVNT
$4.19B
-6,252
Closed -$252K
BDN
1473
Brandywine Realty Trust
BDN
$554M
-29,342
Closed -$283K
BNDX icon
1474
Vanguard Total International Bond ETF
BNDX
$83.1B
-438,542
Closed -$21.7M
BXP icon
1475
Boston Properties
BXP
$11.1B
-5,166
Closed -$464K

Similar funds

Pathstone Family Office's Q3 2022 Portfolio in Review

As of Q3 2022, Pathstone Family Office held 1,539 positions worth $11.1B, up 144% from $4.54B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Pathstone Family Office deployed $7.22B of net new capital in Q3 2022, opening 487 new positions and adding to 956 existing holdings. Its largest new stake was Keurig Dr Pepper: 4,838,386 shares worth $173M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Dimensional US Core Equity Market ETF, an estimated $56.8M trimmed.

  • Pathstone Family Office's largest Q3 2022 buy was Keurig Dr Pepper: 4,838,386 shares worth $173M.
  • Pathstone Family Office added most to iShares Core S&P 500 ETF in Q3 2022, an estimated $460M increase.
  • Pathstone Family Office's biggest Q3 2022 reduction was Dimensional US Core Equity Market ETF, cutting an estimated $56.8M.
  • Pathstone Family Office fully exited Vanguard Total International Bond ETF in Q3 2022, selling an estimated $21.7M.
  • Pathstone Family Office's ten largest holdings make up 33% of its $11.1B portfolio in Q3 2022.
  • Pathstone Family Office opened 487 new positions and closed 69 in Q3 2022.
  • Pathstone Family Office's portfolio value rose 144% quarter-over-quarter to $11.1B.

Based on Pathstone Family Office's 13F filing for Q3 2022, filed 14 Nov 2022.